HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dermalex Eczema ‘Breakthrough’ Claim Breaks Down In UK Review

This article was originally published in The Rose Sheet

Executive Summary

Omega Pharma argues its product provides eczema treatment with multiple benefits commonly available only by using separate products – emollients to protect skin from moisture loss and reducing dryness and topical corticosteroids to reduce inflammation and redness.

Advertisement

Related Content

Omega Pharma's On-Screen Text Fails UK Ad Regulator's Reading Test

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS108979

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel